Overview of Ongoing Clinical Trials on Radioembolization.
作者信息
Fabritius Matthias P, Ricke Jens
机构信息
Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
出版信息
Cardiovasc Intervent Radiol. 2022 Nov;45(11):1659-1662. doi: 10.1007/s00270-022-03270-4. Epub 2022 Oct 2.
Abstract
摘要
相似文献
1
Overview of Ongoing Clinical Trials on Radioembolization.
Cardiovasc Intervent Radiol. 2022 Nov;45(11):1659-1662. doi: 10.1007/s00270-022-03270-4. Epub 2022 Oct 2.
2
⁹⁰Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments.
J Nucl Med. 2015 Jul;56(7):1079-87. doi: 10.2967/jnumed.115.157446. Epub 2015 May 7.
3
A systematic review on the safety and effectiveness of yttrium-90 radioembolization for hepatocellular carcinoma with portal vein tumor thrombosis.
Saudi J Gastroenterol. 2016 Sep-Oct;22(5):353-359. doi: 10.4103/1319-3767.191139.
4
Chemoembolization and radioembolization.
Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):909-19. doi: 10.1016/j.bpg.2014.08.009. Epub 2014 Aug 23.
5
Yttrium-90 Radioembolization for Breast Cancer Liver Metastases.
J Vasc Interv Radiol. 2016 Sep;27(9):1316-1319. doi: 10.1016/j.jvir.2016.06.016.
6
Computational Modeling of Radioembolization: How to Calculate Infinity.
Cardiovasc Intervent Radiol. 2021 Dec;44(12):2020-2021. doi: 10.1007/s00270-021-02989-w. Epub 2021 Oct 26.
7
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.
Gastroenterology. 2011 Feb;140(2):497-507.e2. doi: 10.1053/j.gastro.2010.10.049. Epub 2010 Oct 30.
8
Transarterial chemoembolization and radioembolization.
Semin Liver Dis. 2014 Nov;34(4):435-43. doi: 10.1055/s-0034-1394142. Epub 2014 Nov 4.
9
Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours.
Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):231-7. doi: 10.1007/s00259-013-2550-4. Epub 2013 Sep 13.
10
Yttrium-90 radioembolization-induced abscopal effect on hepatocellular carcinoma.
J Dig Dis. 2022 Apr;23(4):237-239. doi: 10.1111/1751-2980.13092. Epub 2022 Apr 6.
引用本文的文献
1
Expanding the Scope of Interventional Oncology: Locoregional Therapies in Extrahepatic Malignancies.
Cancers (Basel). 2025 Feb 21;17(5):726. doi: 10.3390/cancers17050726.
2
New frontiers in radioembolization.
Ther Adv Med Oncol. 2024 Sep 30;16:17588359241280692. doi: 10.1177/17588359241280692. eCollection 2024.
3
Transarterial Radioembolization for Management of Hepatocellular Carcinoma.
Oncologist. 2024 Feb 2;29(2):117-122. doi: 10.1093/oncolo/oyad327.
本文引用的文献
1
A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma.
Oncologist. 2024 Mar 4;29(3):270-e413. doi: 10.1093/oncolo/oyad331.
2
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
J Hepatol. 2022 Mar;76(3):681-693. doi: 10.1016/j.jhep.2021.11.018. Epub 2021 Nov 19.
3
Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial.
Lancet Gastroenterol Hepatol. 2021 Dec;6(12):1025-1035. doi: 10.1016/S2468-1253(21)00305-8. Epub 2021 Oct 23.
4
Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial.
J Clin Oncol. 2021 Dec 10;39(35):3897-3907. doi: 10.1200/JCO.21.01839. Epub 2021 Sep 20.
5
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745.
Zotero 插件